tiprankstipranks
Ember Therapeutics Inc (EMBT)
OTHER OTC:EMBT
US Market

Ember Therapeutics (EMBT) Income Statement

Compare
4 Followers

Ember Therapeutics Income Statement

Last quarter (Q0 0), Ember Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Ember Therapeutics's net income was $-1.35K. See Ember Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 14Dec 13Dec 12
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―
EBITDA
$ -17.42K$ -11.08K$ -7.87K
Operating Income
$ -17.42K$ -11.08K$ -7.87K
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -23.24K$ -16.33K$ -12.79K
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Ember Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis